MAPT and Alzheimer disease: In the pursuit of an earlier AD diagnosis, it is also questionable whether the detection of amyloid beta (Aβ) plaques and tau biomarkers are specific enough for AD and whether they are only present in established AD cases but not sensitive enough as early diagnostic signs of AD (Klein and Kaye, 2013).